Riskpilot← Back to searchSign inGet full accessIBT Baby AB
ABActiveOrg 5591107353Economic activity was not specified by tax authority · NACE 0000Est. 20170 employees
Revenue 2024
SEK 0
EBITDA margin
—
0% vs 2023
Equity ratio
70.6%
Financial strength
Net profit 2024
SEK -6K
0% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -6K | +0% |
| Net profit | SEK -6K | +0% |
| Total assets | SEK 51K | -91% |
| Equity | SEK 36K | -14% |
| Employees | 0 | — |
Legal name
IBT Baby AB
Org number
5591107353
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
2 maj 2017
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska bedriva förvaltning av och handel med värdepapper för en begränsad och sluten krets av ägare samt bedriva därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −3 | −7 | −5 | −6 | −6 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −3 | −7 | −5 | −6 | −6 |
| Net financials | — | — | — | — | — |
| Profit before tax | −3 | −7 | −5 | −6 | −6 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −3 | −7 | −5 | −6 | −6 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 39 | 67 | 63 | 566 | 51 |
| Equity | 39 | 52 | 48 | 42 | 36 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 15 | 15 | 524 | 15 |
| Total debt | — | 15 | 15 | 524 | 15 |
EBITDA margin
-600000.0%
This company
15.8%
Market median
-3797568% vs market
20202024
Equity ratio
70.6%
This company
38.2%
Market median
+85% vs market
20202024
Return on equity
-16.7%
This company
18.4%
Market median
-191% vs market
20202024
Net profit margin
-600000.0%
This company
8.1%
Market median
-7407507% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.42×
This company
0.62×
Market median
+32% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
SS Chief Executive Officer | Chief Executive Officer | 2022 |
JM Chief Auditor | Chief Auditor | 2022 |
| Former (1) | ||
EB Audit | Audit | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Board of Directors | 2022 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Infant Bacterial Therapeutics AB
IBT Baby AB Board members of IBT Baby AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Staffan Strömberg | Chief Executive Officer | 0 companies |
| Elsa Birgitta Lööf | Audit | 0 companies |
| Jenny Matilda Holmgren | Chief Auditor | 0 companies |
| Peter Michael Rothschild | Chairman | 0 companies |
| Karin Margareta Hagman | Board of Directors | 0 companies |
| Daniel Patrick Mackey | Board of Directors | 0 companies |